MetaCap

Compass Therapeutics Quarterly Balance Sheet

NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6882+0.0097 (+1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Compass Therapeutics financial position

As of Sep 30, 2026, Compass Therapeutics reported total assets of $174.5 million, down 24.5% from a year earlier against total liabilities of $31.9 million. Shareholders' equity stood at $142.6 million, or 81.7% of assets. The company held $41.5 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 6.79, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Compass Therapeutics balance sheet (quarterly)

Compass Therapeutics quarterly balance sheet
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Cash & Equivalents41.47M35.45M55.17M30.64M46.21M22.86M41.05M43.48M19.40M19.40M43.48M24.23M
Short-Term Investments121.59M144.43M139.52M178.26M173.68M78.09M71.59M83.24M98.60M126.82M132.58M128.23M
Total Current Assets165.50M180.89M195.69M209.82M221.12M106.19M124.14M132.75M141.14M153.55M158.61M153.88M
Property, Plant & Equipment402.00K324.00K169.00K102.00K119.00K131.00K102.00K353.00K493.00K592.00K744.00K898.00K
Total Assets174.50M190.17M205.17M219.59M231.26M116.70M131.45M140.40M149.15M155.61M161.14M156.88M
Accounts Payable6.32M2.91M906.00K1.58M3.10M2.60M1.58M2.25M960.00K1.19M854.00K4.09M
Total Current Liabilities24.37M16.13M10.28M13.97M12.41M13.86M14.90M8.87M4.43M9.51M3.89M7.80M
Total Liabilities31.93M24.12M18.70M22.80M21.65M23.49M21.17M15.17M10.75M9.51M4.08M8.34M
Shareholders' Equity142.57M166.05M186.47M196.79M209.61M93.21M110.28M125.23M138.40M146.10M157.06M148.54M
Retained Earnings-501.81M-474.64M-449.49M-431.17M-415.46M-401.20M-381.32M-364.68M-349.65M-339.17M-326.10M-315.31M
Net Cash (Debt)163.06M179.88M194.69M208.91M219.90M100.95M112.64M126.72M118.00M146.23M176.06M152.46M
Shares Outstanding180.09M180.09M180.09M178.32M177.57M138.28M138.28M137.82M137.59M137.59M137.59M127.67M

This table shows 12 quarterly periods of Compass Therapeutics's balance sheet, from Q3 2026 back to Q4 2023, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow CMPX's reporting calendar. What is a balance sheet?

More financial data